• Mechanistically NAergic signaling in the VTA modulates

  2024-03-27

  

  Mechanistically, NAergic signaling in the VTA modulates neuronal activity presumably via α1-AR. The majority of α1-ARs are found in the VTA are located presynaptically on unmyelinated Anastrozole and axon terminals of glutamatergic and GABAergic neurons. However, α1-ARs are also found on neuronal de

• Toxicity is the main reason for

  2024-03-27

  

  Toxicity is the main reason for the failure at all stages of the new drug development process. The major part of safety-related attrition occurs at preclinical phases while predicting preclinical safety liabilities earlier in the drug development process. This strategy enables the design and/or sele

• For the NSCLC patients with

  2024-03-27

  

  For the NSCLC patients with EGFR-activating mutations, EGFR-TKIs (gefitinib and erlotinib) are effective clinical therapies [21], [22]. However, approximately 10% of patients harboring EGFR-sensitizing mutations exhibit intrinsic resistance, and up to 40% do not attain a major response to treatment

• Pompe disease is accompanied by the deficiency of

  2024-03-27

  

  Pompe disease is accompanied by the deficiency of the lysosomal α-1,4-glucosidase that makes the PF-06447475 unable to hydrolyze glycogen to glucose, thereby resulting in the accumulation of glycogen in lysosomes, especially in skeletal muscles and cardiac tissues. This accumulation results in the

• br Conflicts of interest br Introduction Phosphatidic acid p

  2024-03-27

  

  Conflicts of interest Introduction Phosphatidic enfuvirtide synthesis phosphatase (PAP) enzymes are responsible for catalyzing the reaction that dephosphorylates phosphatidic acid (PA), which in turn produces diacylglycerol (DAG) and a phosphate group during phospholipid regulation (Fig. 1A)

• br Conclusions A large body of

  2024-03-26

  

  Conclusions A large body of evidence indicates that oxidative stress is involved in the pathogenesis of NDDs. Hence, reducing oxidative stress or suppressing its downstream pathways may be beneficial for the treatment of these diseases, especially such chronic diseases as AD or glaucoma. Here we

• Over expression of the inflammatory cytokines

  2024-03-26

  

  Over expression of the inflammatory cytokines, MMPs and COX-2 act as an important inducer of chronic inflammation. COX-2 catalyzes the biosynthesis of prostaglandins (PGs), and induced expression was observed in Oprozomib stimulated with pro-inflammatory cytokines or bacterial lipopolysaccharide (K

• Although sex hormones activational effects are known to dire

  2024-03-26

  

  Although sex hormones (activational effects) are known to directly interact with RAS (Baiardi et al., 2005, Miller et al., 1999, Silbiger and Neugarten, 1995), the potential contribution of organizational hormonal and SCC effects on physiological sex-based difference in the regulation of the RAS rem

• Women are usually at risk of sleep deprivation or

  2024-03-26

  

  Women are usually at risk of sleep deprivation or restriction during pregnancy, especially in the third trimester of gestation, due to the pregnancy-associated anatomic, physiological and hormonal changes (Pien and Schwab, 2004). However, several major exportin developmental events, such as the neur

• It remains to elucidate whether proteolytic activity

  2024-03-26

  

  It remains to elucidate whether proteolytic activity is the cause or the consequence of changing levels of peptidergic substrates. In fact, in some cases, the expression of the enzyme does not necessarily parallel with its activity [26], [55], [57] and other factors such as a definite biochemical en

• TGX-221 mg LOXs and CYPs are a series of iron containing enz

  2024-03-26

  

  LOXs and CYPs are a series of iron-containing enzymes that metabolize arachidonic TGX-221 mg to form biologically active products, such as epoxyeicosatrienoic acids (EETs) hydroperoxyeicosatetraenoic acids (HETEs), prostaglandins, leukotrienes and thromboxanes [6]. Among these mediators, 12/15LOX h

• br Introduction Alzheimer s disease AD is

  2024-03-26

  

  Introduction Alzheimer's disease (AD) is a neurodegenerative disorder and the leading cause of dementia. It is characterized by progressive and irreversible damage to different amiodarone hcl areas, resulting in cognitive impairment and behavioral changes (O'Neill, 2013, De Strooper and Karran, 2

• Several genes related to metabolism post

  2024-03-25

  

  Several genes related to metabolism, post-transcriptional regulation, chromatin structure, and signaling pathways are required for the sexual development and virulence of G. zeae (Baldwin et al., 2010, Bluhm et al., 2007, Ding et al., 2009, Han et al., 2007, Hou et al., 2002, Jenczmionka et al., 200

• In this review we will present the traditional and

  2024-03-25

  

  In this review, we will present the traditional and actual strategies to study orphan receptors and identify their ligands. An extensive description of the orphan GPCR field has been published in 2013 by Davenport et al. [22]. Therefore, we will focus on the deorphanizations that were reported since

• br Conflicts of interest br Introduction Photodynamic Therap

  2024-03-25

  

  Conflicts of interest Introduction Photodynamic Therapy (PDT) is a technique used for the treatment of several malignant and non malignant diseases (Akimoto, 2016, Keyal, Bhatta, Wang, 2016, Morton, Szeimies, Sidoroff, Wennberg, Basset-Seguin, Calzavara-Pinton, Gilaberte, Hofbauer, Hunger, Ka

16604 records 184/1107 page Previous Next First page 上5页 181182183184185 下5页 Last page